To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FDPSTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
728 representative clones for gene FDPS back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BE741165 adenocarcinoma cell line, ovary .a 1 to 758 1 to 755   tiling clone,   755/755
(100 %)
6 diff
(99.3 %id)
BE898380 adenocarcinoma cell line, ovary .a 445 to 1239 1 to 795       795/925
(85 %)
21 diff
(97.8 %id)
TI_57167510   .a 637 to 1326 56 to 745       690/1006
(68 %)
19 diff
(98.2 %id)
BI835285 pooled pancreas and spleen .a 646 to 1326 1 to 681       681/942
(72 %)
11 diff
(98.9 %id)
BQ071518 brain, neuroblastoma, cell line .a 673 to 1348 1 to 676   tiling clone, AAA   676/676
(100 %)
0 diff
(100 %id)
NM_002004.3   .b 1 to 1536 1 to 1536 exact RefSeq, AAA   1536/1536
(100 %)
0 diff
(100 %id)
BU595949 mixed (pool of 40 RNAs) .b 102 to 839 1 to 746   tiling clone,   744/811
(91 %)
13 diff
(98.4 %id)
BU508600 leiomyosarcoma, uterus .b 117 to 989 1 to 880   AAA   880/906
(97 %)
13 diff
(98.6 %id)
BP264323 small intestine .b 125 to 706 1 to 582       582/583
(99 %)
7 diff
(98.8 %id)
BQ055281 lymph, lymphoma, cell line .b 135 to 1070 1 to 945       945/1063
(88 %)
21 diff
(98.1 %id)
BQ055862 lymph, lymphoma, cell line .b 136 to 989 1 to 865       860/1062
(80 %)
20 diff
(98.2 %id)
BQ062373 lymph, lymphoma, cell line .b 136 to 1073 1 to 946       923/1005
(91 %)
18 diff
(98.3 %id)
BQ882982 lymph, lymphoma, cell line .b 136 to 907 1 to 776       776/828
(93 %)
8 diff
(99.1 %id)
BG769214 melanotic melanoma, high MDR (cell line), skin .b 141 to 894 1 to 781       688/847
(81 %)
30 diff
(96.5 %id)
BP252440 Kidney .b 143 to 722 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BF973026 leiomyosarcoma cell line, uterus .b 151 to 841 1 to 689       689/692
(99 %)
9 diff
(98.7 %id)
BG338298 leiomyosarcoma cell line, uterus .b 151 to 952 1 to 794       794/862
(92 %)
17 diff
(98.1 %id)
BQ063727 lymph, lymphoma, cell line .b 152 to 991 1 to 840       840/1046
(80 %)
6 diff
(99.5 %id)
BQ066228 lymph, lymphoma, cell line .b 152 to 1061 1 to 921       921/1008
(91 %)
21 diff
(98.0 %id)
BG742062 skin .b 153 to 1070 1 to 914       914/954
(95 %)
22 diff
(97.7 %id)
BG746365 adenocarcinoma cell line, colon .b 160 to 992 1 to 828       828/925
(89 %)
15 diff
(98.4 %id)
CR599124 Placenta Cot 25-normalized .b 176 to 1505 1 to 1330 exact     1330/1330
(100 %)
0 diff
(100 %id)
AL546559 placenta, Placenta Cot 25-normalized .b 176 to 730 1 to 555   fully sequenced,   555/555
(100 %)
0 diff
(100 %id)
BE747448 adenocarcinoma cell line, ovary .b 176 to 1066 37 to 920       884/981
(90 %)
46 diff
(95.4 %id)
CV804767 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 177 to 951 1 to 774       774/774
(100 %)
8 diff
(99.0 %id)
BG387755 embryonal carcinoma, cell line, testis .b 186 to 905 1 to 715       715/946
(75 %)
13 diff
(98.7 %id)
BP255550 Kidney .b 189 to 769 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM791018 stomach .b 190 to 614 1 to 425       425/425
(100 %)
0 diff
(100 %id)
BM817776 stomach .b 190 to 815 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
BE271957.
matches multiple genes
adenocarcinoma cell line, ovary, Ovary, adenocarcinoma .b 195 to 862 1 to 664   available from MGC, also hits gene EEF1A1 664/684
(97 %)
21 diff
(97.0 %id)
BE745776 adenocarcinoma cell line, ovary .b 197 to 953 1 to 763       763/954
(79 %)
24 diff
(97.5 %id)
AK291084   .b 200 to 1535 1 to 1336 exact tiling clone,   1336/1336
(100 %)
0 diff
(100 %id)
DA618852   .b 201 to 776 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA728964   .b 201 to 948 2 to 750   capped   749/751
(99 %)
6 diff
(99.3 %id)
BM047298 carcinoma, cell line, Prostate .b 204 to 1057 1 to 862       860/922
(93 %)
27 diff
(97.1 %id)
BM917726 blood, natural killer cells, cell line .b 204 to 779 18 to 593       576/1106
(52 %)
8 diff
(99.3 %id)
BQ895806 carcinoma, cell line, Prostate .b 206 to 993 1 to 793       793/918
(86 %)
7 diff
(99.3 %id)
BU502711 carcinoma, cell line, Prostate .b 206 to 1109 1 to 908       908/909
(99 %)
9 diff
(99.1 %id)
BU543728 carcinoma, cell line, Prostate .b 206 to 1073 1 to 869       869/901
(96 %)
9 diff
(99.1 %id)
BG165305 hypernephroma, cell line, Kidney .b 208 to 724 1 to 517       517/519
(99 %)
3 diff
(99.5 %id)
BM561683 blood, natural killer cells, cell line .b 210 to 1149 1 to 943       943/1026
(91 %)
18 diff
(98.3 %id)
BM563960 blood, natural killer cells, cell line .b 210 to 868 12 to 677       666/1368
(48 %)
18 diff
(98.7 %id)
BF308442 muscle, rhabdomyosarcoma .b 211 to 987 1 to 761       761/919
(82 %)
34 diff
(96.4 %id)
BG750329 eye, normal pigmented retinal epithelium .b 211 to 954 1 to 743       743/744
(99 %)
3 diff
(99.6 %id)
TI_1948093572   .b 211 to 858 122 to 771   fully sequenced,   650/771
(84 %)
7 diff
(99.1 %id)
BC010004 Muscle, rhabdomyosarcoma .b 212 to 1535 1 to 1324 exact available from MGC, AAA   1324/1324
(100 %)
0 diff
(100 %id)
BU190753 ductal carcinoma, cell line, Pancreas .b 213 to 1073 1 to 861       861/1038
(82 %)
11 diff
(99.0 %id)
BU174823 ductal carcinoma, cell line, Pancreas .b 213 to 1066 1 to 866       866/1009
(85 %)
19 diff
(98.2 %id)
BQ892963 ductal carcinoma, cell line, Pancreas .b 213 to 1113 1 to 904       904/905
(99 %)
16 diff
(98.3 %id)
BQ689888 ductal carcinoma, cell line, Pancreas .b 213 to 1070 1 to 862       862/863
(99 %)
12 diff
(98.7 %id)
BQ686992 ductal carcinoma, cell line, Pancreas .b 213 to 1070 1 to 861       861/948
(90 %)
10 diff
(99.0 %id)
BX446461 placenta .b 216 to 1278 1 to 1063       1063/1063
(100 %)
10 diff
(99.1 %id)
BE799213 lung, small cell carcinoma .b 217 to 994 1 to 768       768/890
(86 %)
16 diff
(98.3 %id)
BU850057 ovary, teratocarcinoma, cell line .b 218 to 1100 1 to 884       884/884
(100 %)
6 diff
(99.4 %id)
TI_1948093731   .b 220 to 934 129 to 849   fully sequenced,   721/849
(84 %)
7 diff
(99.2 %id)
TI_1948094065   .b 220 to 936 129 to 847   fully sequenced,   719/847
(84 %)
9 diff
(99.0 %id)
BE790907 lung, small cell carcinoma .b 229 to 994 1 to 766   AAA   766/858
(89 %)
6 diff
(99.4 %id)
AA078902   .b 231 to 667 1 to 444       444/444
(100 %)
7 diff
(98.5 %id)
BG330430 large cell carcinoma, lung .b 232 to 990 1 to 754       754/815
(92 %)
19 diff
(97.7 %id)
BE799621 lung, small cell carcinoma .b 233 to 983 34 to 781       748/782
(95 %)
12 diff
(98.5 %id)
BE266727 lung, small cell carcinoma .b 251 to 824 1 to 574       574/574
(100 %)
0 diff
(100 %id)
CU444306 epidermis .b 298 to 954 694 to 38     Submitted on the opposite strand 657/694
(94 %)
2 diff
(99.8 %id)
BE696653 colon .b 342 to 542 201 to 1       201/201
(100 %)
0 diff
(100 %id)
BM909426 lymph, lymphoma, cell line .b 351 to 1067 1 to 717       717/1038
(69 %)
5 diff
(99.6 %id)
BQ062355 lymph, lymphoma, cell line .b 351 to 1279 1 to 938       938/1007
(93 %)
12 diff
(98.9 %id)
BQ062325 lymph, lymphoma, cell line .b 352 to 1277 1 to 937       937/1010
(92 %)
21 diff
(98.0 %id)
CD613697   .b 391 to 691 1 to 298       298/317
(94 %)
7 diff
(97.8 %id)
CD613696   .b 394 to 691 314 to 18       297/317
(93 %)
1 diff
(99.7 %id)
CN346004 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 395 to 1092 1 to 697       697/697
(100 %)
2 diff
(99.8 %id)
CN346006 embryonic stem cells, cell lines H1, H7, andH9 .b 395 to 605 1 to 211       211/211
(100 %)
1 diff
(99.6 %id)
AW245222 lung, small cell carcinoma .b 396 to 935 18 to 558       541/558
(96 %)
6 diff
(99.0 %id)
BG680159 skin, squamous cell carcinoma .b 396 to 1220 1 to 822       822/1000
(82 %)
18 diff
(98.2 %id)
AA129543 lung, lung carcinoma .b 398 to 647 1 to 254       254/302
(84 %)
6 diff
(98.1 %id)
BI226647 Burkitt lymphoma, lymph .b 398 to 1260 1 to 865       865/865
(100 %)
7 diff
(99.2 %id)
BX403290 Neuroblastoma Cot 10-normalized .b 400 to 1066 1 to 668       668/877
(76 %)
17 diff
(98.1 %id)
BE796581 lung, small cell carcinoma .b 400 to 1126 1 to 725       725/727
(99 %)
3 diff
(99.6 %id)
CB145601 Liver .b 400 to 800 1 to 401       401/401
(100 %)
1 diff
(99.8 %id)
BE250868 eye, retinoblastoma .b 401 to 994 1 to 590       590/592
(99 %)
7 diff
(98.9 %id)
BE792873 lung, small cell carcinoma .b 401 to 1220 1 to 811       811/818
(99 %)
23 diff
(97.2 %id)
BE732902 choriocarcinoma, placenta .b 406 to 1181 1 to 775       775/779
(99 %)
7 diff
(99.2 %id)
BE778368 eye, retinoblastoma .b 406 to 1073 1 to 664       664/931
(71 %)
12 diff
(98.8 %id)
BE256063 eye, retinoblastoma .b 407 to 993 1 to 590       590/611
(96 %)
11 diff
(98.2 %id)
TI_59390513   .b 408 to 1278 101 to 967       867/891
(97 %)
17 diff
(98.1 %id)
BM910901 astrocytoma grade IV, cell line, brain .b 410 to 1273 1 to 863       863/1088
(79 %)
12 diff
(98.9 %id)
AL571867 placenta, Placenta Cot 25-normalized .b 669 to 1505 839 to 1   fully sequenced,   839/839
(100 %)
2 diff
(99.8 %id)
TI_1948093573   .b 828 to 1481 794 to 133   fully sequenced,   662/794
(83 %)
9 diff
(98.9 %id)
TI_1948093732   .b 873 to 1481 721 to 108   fully sequenced,   614/721
(85 %)
0 diff
(100 %id)
TI_1948094066   .b 894 to 1481 690 to 102   fully sequenced,   589/690
(85 %)
7 diff
(99.0 %id)
AW249692 lung, small cell carcinoma .b 938 to 1535 608 to 11   AAA   598/598
(100 %)
0 diff
(100 %id)
DB354007   .b 987 to 1535 547 to 1       547/565
(96 %)
13 diff
(97.7 %id)
AA078786   .b 1226 to 1535 310 to 2       309/310
(99 %)
0 diff
(100 %id)
NM_001135821.1   .c 1 to 1481 1 to 1481 exact RefSeq, AAA   1481/1481
(100 %)
0 diff
(100 %id)
BU846450 ovary, teratocarcinoma, cell line .c 3 to 848 1 to 851   tiling clone,   851/904
(94 %)
13 diff
(98.6 %id)
CR598280 Neuroblastoma Cot 25-normalized .c 16 to 1471 1 to 1456 exact     1456/1456
(100 %)
0 diff
(100 %id)
DA000783   .c 34 to 554 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
BP362766 thalamus .c 34 to 615 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP193371 brain .c 35 to 615 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP230389 brain .c 35 to 626 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BP253124 Kidney .c 35 to 615 1 to 581       581/581
(100 %)
0 diff
(100 %id)
AU128061   .c 36 to 610 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA969065 stomach .c 36 to 576 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BQ934562 large cell carcinoma, lung .c 48 to 784 1 to 745       745/828
(89 %)
11 diff
(98.7 %id)
D14697   .c 51 to 1480 1 to 1430 exact tiling clone, available from KIAA,   1430/1430
(100 %)
0 diff
(100 %id)
BI116606 lung, small cell carcinoma .c 51 to 725 1 to 683       683/705
(96 %)
14 diff
(98.1 %id)
BE747466 adenocarcinoma cell line, ovary .c 52 to 686 41 to 676       636/676
(94 %)
9 diff
(98.7 %id)
BG395403 eye, retinoblastoma .c 54 to 939 1 to 889       889/1035
(85 %)
36 diff
(96.6 %id)
BQ214553 melanotic melanoma, skin .c 59 to 923 1 to 874       874/879
(99 %)
15 diff
(98.3 %id)
BQ944776 carcinoma, cell line, Prostate .c 63 to 904 1 to 851       851/903
(94 %)
16 diff
(98.3 %id)
BE740739 adenocarcinoma cell line, ovary .c 64 to 850 1 to 788       788/855
(92 %)
19 diff
(97.8 %id)
BE312025 brain, neuroblastoma .c 80 to 558 1 to 479       479/480
(99 %)
1 diff
(99.8 %id)
AU150389   .c 895 to 1480 587 to 1       587/588
(99 %)
15 diff
(97.5 %id)
BU174696 ductal carcinoma, cell line, Pancreas .d 1 to 850 1 to 856   tiling clone,   856/952
(89 %)
18 diff
(98.2 %id)
BQ686242 ductal carcinoma, cell line, Pancreas .d 1 to 850 1 to 862       862/870
(99 %)
9 diff
(99.0 %id)
BI192924 epithelioid carcinoma cell line, Pancreas .d 4 to 659 1 to 653       653/685
(95 %)
21 diff
(97.0 %id)
BM012166 brain, neuroblastoma, cell line .d 4 to 771 1 to 774       770/774
(99 %)
13 diff
(98.4 %id)
TI_59381368   .d 4 to 771 93 to 866       770/774
(99 %)
13 diff
(98.4 %id)
TI_154172129   .d 4 to 702 89 to 785       697/1223
(56 %)
17 diff
(98.7 %id)
BG419121 Kidney, renal cell adenocarcinoma .d 5 to 701 1 to 696       696/906
(76 %)
14 diff
(98.5 %id)
BI257971 cervical carcinoma cell line, cervix .d 5 to 671 1 to 667       667/670
(99 %)
1 diff
(99.9 %id)
BG420188 Kidney, renal cell adenocarcinoma .d 6 to 660 1 to 654       654/657
(99 %)
9 diff
(98.7 %id)
BM015398 breast, mammary adenocarcinoma, cell line .d 6 to 657 1 to 639       639/639
(100 %)
17 diff
(97.4 %id)
BM474626 eye, retinoblastoma .d 6 to 776 1 to 771       771/1021
(75 %)
13 diff
(98.8 %id)
BU855274 ovary, teratocarcinoma, cell line .d 9 to 772 1 to 767       767/873
(87 %)
10 diff
(98.9 %id)
BG682989 brain, neuroblastoma, cell line .d 10 to 748 1 to 740       740/744
(99 %)
11 diff
(98.6 %id)
BM012538 brain, neuroblastoma, cell line .d 10 to 655 1 to 646       646/655
(98 %)
2 diff
(99.7 %id)
TI_59381756   .d 11 to 655 63 to 707       645/654
(98 %)
1 diff
(99.9 %id)
CN346009 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 12 to 625 1 to 614       614/614
(100 %)
0 diff
(100 %id)
CX870893 embryonic stem .d 12 to 723 1 to 712       712/712
(100 %)
0 diff
(100 %id)
BG396306 eye, retinoblastoma .d 13 to 751 1 to 730       730/832
(87 %)
17 diff
(98.0 %id)
BF797043 lymph, lymphoma, cell line .d 14 to 679 1 to 666       666/666
(100 %)
11 diff
(98.4 %id)
BF306038 muscle, rhabdomyosarcoma .d 17 to 751 1 to 729       729/793
(91 %)
19 diff
(97.7 %id)
BM046869 carcinoma, cell line, Prostate .d 17 to 705 1 to 689       689/689
(100 %)
3 diff
(99.6 %id)
CV811471 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 19 to 727 1 to 709       709/709
(100 %)
0 diff
(100 %id)
BE311567 Kidney, renal cell adenocarcinoma .d 25 to 671 1 to 636       636/723
(87 %)
22 diff
(97.0 %id)
BE257992 eye, retinoblastoma .d 26 to 696 1 to 669       669/766
(87 %)
15 diff
(98.1 %id)
BE257005 eye, retinoblastoma .d 26 to 681 1 to 650       650/756
(85 %)
11 diff
(98.6 %id)
BE273046 Kidney, renal cell adenocarcinoma .d 31 to 667 1 to 629       629/718
(87 %)
14 diff
(98.1 %id)
BE900661 choriocarcinoma, placenta .d 32 to 772 1 to 731       731/868
(84 %)
22 diff
(97.5 %id)
BE407978 choriocarcinoma, placenta .d 34 to 700 1 to 664       664/665
(99 %)
10 diff
(98.5 %id)
BE784017 eye, retinoblastoma .d 35 to 629 1 to 597       597/598
(99 %)
13 diff
(97.9 %id)
TI_59393632   .d 46 to 657 135 to 737       603/737
(81 %)
17 diff
(97.7 %id)
AW361720 colon .d 493 to 1046 554 to 1   tiling clone,   554/555
(99 %)
3 diff
(99.5 %id)
BM797909 Ascites, stomach .d 816 to 1290 1 to 475   tiling clone,   475/475
(100 %)
3 diff
(99.4 %id)
DA610405   .e 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
BU165165 eye, retinoblastoma .e 18 to 761 36 to 785       750/903
(83 %)
14 diff
(98.5 %id)
DB502602 hypothalamus .e 26 to 495 1 to 470       470/470
(100 %)
2 diff
(99.6 %id)
BP217959 caudate nucleus .e 33 to 614 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DT218804 brain .e 33 to 680 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BP245687 Kidney .e 33 to 614 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
AU100019   .e 33 to 332 1 to 300       300/300
(100 %)
6 diff
(98.0 %id)
BP273943   .e 33 to 599 1 to 567       567/567
(100 %)
7 diff
(98.8 %id)
CB108932 Liver .e 33 to 430 1 to 398       398/398
(100 %)
0 diff
(100 %id)
DA687341   .e 34 to 568 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
BM832481 stomach .e 34 to 541 1 to 508       508/508
(100 %)
0 diff
(100 %id)
AI879367 brain, frontal lobe .e 36 to 670 4 to 638       635/706
(89 %)
17 diff
(97.6 %id)
CN401892 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 37 to 753 5 to 720       716/720
(99 %)
7 diff
(99.1 %id)
BG683020 brain, neuroblastoma, cell line .e 41 to 701 1 to 666   fully sequenced,   666/666
(100 %)
11 diff
(98.4 %id)
BQ070182 brain, neuroblastoma, cell line .e 41 to 674 1 to 638       638/1013
(62 %)
8 diff
(99.3 %id)
AI929318 brain, frontal lobe .e 42 to 782 1 to 742       742/742
(100 %)
12 diff
(98.4 %id)
BG481213 choriocarcinoma, placenta .e 42 to 833 1 to 790       790/799
(98 %)
13 diff
(98.4 %id)
BG437242 large cell carcinoma, lung .e 44 to 905 1 to 865       863/865
(99 %)
24 diff
(97.3 %id)
BG471910 eye, retinoblastoma .e 44 to 760 1 to 723       723/782
(92 %)
19 diff
(97.6 %id)
BQ063638 lymph, lymphoma, cell line .e 44 to 901 1 to 865       865/1045
(82 %)
14 diff
(98.7 %id)
BQ064198 lymph, lymphoma, cell line .e 44 to 916 1 to 879       879/998
(88 %)
16 diff
(98.4 %id)
BQ064257 lymph, lymphoma, cell line .e 44 to 884 1 to 845       843/911
(92 %)
4 diff
(99.6 %id)
BG336643 choriocarcinoma, placenta .e 45 to 760 1 to 705       705/959
(73 %)
19 diff
(98.1 %id)
BG480078 choriocarcinoma, placenta .e 45 to 880 1 to 840       840/840
(100 %)
13 diff
(98.5 %id)
BI256408 cervical carcinoma cell line, cervix .e 45 to 911 1 to 869       869/876
(99 %)
7 diff
(99.3 %id)
CV811896 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 45 to 840 1 to 800       800/894
(89 %)
15 diff
(98.4 %id)
BM012059 brain, neuroblastoma, cell line .e 51 to 761 1 to 714       712/718
(99 %)
9 diff
(98.8 %id)
BM011979 brain, neuroblastoma, cell line .e 51 to 840 1 to 790       790/899
(87 %)
29 diff
(96.8 %id)
BQ924334 large cell carcinoma, lung .e 51 to 911 12 to 873   tiling clone,   862/935
(92 %)
10 diff
(99.0 %id)
BU846325 ovary, teratocarcinoma, cell line .e 51 to 911 1 to 866       866/914
(94 %)
9 diff
(99.1 %id)
TI_59381166   .e 51 to 840 97 to 886       790/899
(87 %)
29 diff
(96.8 %id)
TI_59381255   .e 51 to 761 94 to 807       712/718
(99 %)
9 diff
(98.8 %id)
CN401893 embryonic stem cells, cell lines H1, H7, andH9 .e 53 to 666 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
BF308660 muscle, rhabdomyosarcoma .e 53 to 780 1 to 726       726/727
(99 %)
11 diff
(98.5 %id)
BG330934 large cell carcinoma, lung .e 53 to 759 1 to 702       702/934
(75 %)
22 diff
(97.7 %id)
BG335435 choriocarcinoma, placenta .e 54 to 761 1 to 709       709/904
(78 %)
12 diff
(98.7 %id)
BG335604 choriocarcinoma, placenta .e 54 to 674 1 to 619       619/838
(73 %)
9 diff
(99.0 %id)
BI115207 muscle, rhabdomyosarcoma .e 54 to 785 1 to 728       728/728
(100 %)
9 diff
(98.8 %id)
BM464746 lymph, lymphoma, cell line .e 55 to 998 1 to 953       952/1156
(82 %)
23 diff
(98.1 %id)
BF974979 B-cells, primary B-cells from tonsils (cell line) .e 57 to 833 1 to 771       771/785
(98 %)
15 diff
(98.1 %id)
BG166918 hypernephroma, cell line, Kidney .e 57 to 648 1 to 590       590/590
(100 %)
4 diff
(99.4 %id)
BG333795 melanotic melanoma, skin .e 59 to 798 1 to 737       737/737
(100 %)
5 diff
(99.4 %id)
BM013381 brain, neuroblastoma, cell line .e 60 to 916 1 to 859       859/896
(95 %)
16 diff
(98.3 %id)
TI_59380199   .e 60 to 916 97 to 955       859/896
(95 %)
16 diff
(98.3 %id)
BQ071806 brain, neuroblastoma, cell line .e 62 to 973 1 to 921       921/1085
(84 %)
21 diff
(98.1 %id)
CN401894 embryonic stem cells, DMSO-treated H9 cellline .e 63 to 540 1 to 478       478/478
(100 %)
0 diff
(100 %id)
CF140725 CNCAP(3)T-225 cell line, Prostate .e 63 to 346 1 to 284       284/284
(100 %)
5 diff
(98.3 %id)
BE295697 muscle, rhabdomyosarcoma .e 73 to 721 1 to 647       645/708
(91 %)
15 diff
(97.9 %id)
BE295521 muscle, rhabdomyosarcoma .e 74 to 700 1 to 626       626/629
(99 %)
7 diff
(98.9 %id)
BE280669 choriocarcinoma, placenta .e 76 to 746 1 to 665       665/689
(96 %)
25 diff
(96.4 %id)
BE746633 adenocarcinoma cell line, ovary .e 77 to 795 1 to 714       714/714
(100 %)
11 diff
(98.5 %id)
BE745482 adenocarcinoma cell line, ovary .e 77 to 818 1 to 726       726/941
(77 %)
20 diff
(97.9 %id)
BE514623 adenocarcinoma cell line, ovary .e 78 to 734 1 to 650       650/650
(100 %)
11 diff
(98.4 %id)
BE514866 adenocarcinoma cell line, ovary .e 78 to 755 1 to 671       671/673
(99 %)
13 diff
(98.1 %id)
BE742615 adenocarcinoma cell line, ovary .e 78 to 892 1 to 805       805/965
(83 %)
19 diff
(98.1 %id)
BE251900 eye, retinoblastoma .e 80 to 724 1 to 639       639/716
(89 %)
8 diff
(98.9 %id)
BE546732 cervical carcinoma cell line, cervix .e 81 to 818 1 to 726       726/791
(91 %)
24 diff
(97.0 %id)
BQ632718 Pancreas, Purified pancreatic islet .e 83 to 728 1 to 645       645/645
(100 %)
2 diff
(99.7 %id)
BG683520 brain, neuroblastoma, cell line .e 640 to 1227 598 to 1   fully sequenced,   598/598
(100 %)
10 diff
(98.4 %id)
BQ632430 Pancreas, Purified pancreatic islet .e 861 to 1302 446 to 5   tiling clone,   442/446
(99 %)
0 diff
(100 %id)
BI090279 cervix .f 1 to 793 1 to 802   tiling clone,   800/827
(96 %)
19 diff
(97.8 %id)
CB142528 Liver .f 6 to 567 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
CB114096 Liver .f 16 to 537 1 to 522       522/522
(100 %)
3 diff
(99.5 %id)
CB148728 Liver .f 16 to 541 1 to 526       526/526
(100 %)
0 diff
(100 %id)
BP341520 stomach mucosa .f 16 to 599 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BP342429 stomach mucosa .f 16 to 598 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA066132 cerebellum .f 17 to 505 2 to 491   capped   490/490
(100 %)
1 diff
(99.8 %id)
BP224820   .f 17 to 599 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DT218007 brain .f 17 to 594 1 to 578       578/578
(100 %)
0 diff
(100 %id)
DA691793   .f 18 to 585 2 to 572   capped   571/571
(100 %)
4 diff
(99.3 %id)
DA923527 small intestine .f 18 to 597 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
CF141428 CNCAP(3)T-225 cell line, Prostate .f 27 to 563 7 to 543       537/543
(98 %)
7 diff
(98.8 %id)
BF685198 leiomyosarcoma cell line, uterus .f 28 to 509 1 to 493       493/625
(78 %)
21 diff
(96.7 %id)
BF973251 leiomyosarcoma cell line, uterus .f 31 to 873 1 to 840       840/1085
(77 %)
23 diff
(97.9 %id)
BQ431665 eye, retinoblastoma .f 31 to 947 1 to 930       925/930
(99 %)
21 diff
(97.8 %id)
CX869421 embryonic stem .f 31 to 630 1 to 600       600/600
(100 %)
0 diff
(100 %id)
CB114978 Liver .f 32 to 618 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
CN346016 embryonic stem cells, cell lines H1, H7, andH9 .f 35 to 594 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
BQ940749 brain, neuroblastoma, cell line .f 35 to 867 1 to 836       836/836
(100 %)
4 diff
(99.6 %id)
BQ926986 brain, neuroblastoma, cell line .f 35 to 946 1 to 915       913/932
(97 %)
18 diff
(98.1 %id)
BG395610 eye, retinoblastoma .f 36 to 835 1 to 794       794/912
(87 %)
28 diff
(97.0 %id)
BQ898548 brain, neuroblastoma, cell line .f 36 to 928 1 to 897       897/897
(100 %)
8 diff
(99.2 %id)
DN602285 human embryonic stem cells .f 36 to 897 1 to 862       862/862
(100 %)
0 diff
(100 %id)
BP247563 Kidney .f 37 to 618 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP247570 Kidney .f 37 to 617 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BG829285 muscle, rhabdomyosarcoma .f 37 to 609 1 to 572       572/572
(100 %)
1 diff
(99.9 %id)
BU179402 melanotic melanoma, cell line, skin .f 37 to 614 1 to 584       584/937
(62 %)
13 diff
(98.7 %id)
CR596980 Neuroblastoma Cot 10-normalized .f 39 to 1236 1 to 1198 exact tiling clone,   1198/1198
(100 %)
0 diff
(100 %id)
AL521964 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 39 to 752 1 to 714   fully sequenced,   714/714
(100 %)
3 diff
(99.6 %id)
BQ424542 melanotic melanoma, skin .f 39 to 867 27 to 856       830/857
(96 %)
10 diff
(98.9 %id)
BG774905 carcinoma, cell line, Prostate .f 40 to 825 1 to 794   fully sequenced,   792/792
(100 %)
9 diff
(98.9 %id)
CN346022 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 45 to 289 1 to 245       245/247
(99 %)
4 diff
(98.4 %id)
BE901672 choriocarcinoma, placenta .f 46 to 867 1 to 815       815/954
(85 %)
26 diff
(97.3 %id)
BI114980 muscle, rhabdomyosarcoma .f 46 to 608 1 to 581       578/852
(67 %)
26 diff
(97.0 %id)
BE262009 brain, neuroblastoma .f 47 to 458 1 to 418       413/418
(98 %)
9 diff
(97.9 %id)
BQ434542 melanotic melanoma, skin .f 55 to 862 1 to 811       811/849
(95 %)
10 diff
(98.9 %id)
BE900446 choriocarcinoma, placenta .f 56 to 929 1 to 877       877/931
(94 %)
36 diff
(96.2 %id)
BE792170 lung, small cell carcinoma .f 57 to 872 1 to 805       805/831
(96 %)
19 diff
(97.8 %id)
BE899063 adenocarcinoma cell line, ovary .f 62 to 623 1 to 579       551/673
(81 %)
20 diff
(97.1 %id)
AL562046 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .f 691 to 1215 546 to 22   fully sequenced,   525/546
(96 %)
9 diff
(98.4 %id)
BG775368 carcinoma, cell line, Prostate .f 764 to 1214 454 to 2   fully sequenced,   453/454
(99 %)
2 diff
(99.6 %id)
CX869343 embryonic stem .f 781 to 1264 517 to 34   tiling clone, AAA   484/484
(100 %)
9 diff
(98.2 %id)
NM_001135822.1   .g 1 to 1338 1 to 1338 exact RefSeq, AAA   1338/1338
(100 %)
0 diff
(100 %id)
CB144686 Liver .g 85 to 328 1 to 244       244/244
(100 %)
0 diff
(100 %id)
CB133111 Liver .g 85 to 541 1 to 457   tiling clone,   457/457
(100 %)
0 diff
(100 %id)
BP246682 Kidney .g 93 to 680 1 to 588       588/588
(100 %)
0 diff
(100 %id)
DA929993 small intestine .g 94 to 653 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA960337 Spleen .g 94 to 653 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CB145549 Liver .g 102 to 598 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BQ055194 lymph, lymphoma, cell line .g 106 to 1021 1 to 926       926/1074
(86 %)
13 diff
(98.8 %id)
BQ065800 lymph, lymphoma, cell line .g 106 to 1021 1 to 928       928/1022
(90 %)
20 diff
(98.1 %id)
BQ053347 blood, natural killer cells, cell line .g 109 to 975 1 to 874       874/1088
(80 %)
14 diff
(98.8 %id)
BU539675 adenocarcinoma, cell line, breast .g 109 to 946 1 to 841       841/883
(95 %)
7 diff
(99.3 %id)
CX871556 embryonic stem .g 109 to 907 1 to 799       799/799
(100 %)
1 diff
(99.9 %id)
CX758963 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .g 114 to 864 1 to 751     Submitted on the opposite strand 751/751
(100 %)
1 diff
(99.9 %id)
BQ787164 Pancreas, Purified pancreatic islet .g 117 to 792 12 to 687       676/687
(98 %)
6 diff
(99.2 %id)
CR981769 T-Lymphocytes .g 117 to 905 1 to 789       789/789
(100 %)
0 diff
(100 %id)
CR990284 T-Lymphocytes .g 117 to 905 1 to 791       791/793
(99 %)
7 diff
(99.2 %id)
CT004054 T-Lymphocytes .g 117 to 864 1 to 747       747/747
(100 %)
1 diff
(99.9 %id)
BQ679165 melanotic melanoma, cell line, skin .g 118 to 1022 1 to 915       915/921
(99 %)
12 diff
(98.7 %id)
BU182322 eye, retinoblastoma .g 119 to 1015 1 to 905       905/905
(100 %)
11 diff
(98.8 %id)
BQ058201 lymph, lymphoma, cell line .g 120 to 1075 1 to 967       967/1022
(94 %)
26 diff
(97.5 %id)
BQ642904 lymph, lymphoma, cell line .g 120 to 937 1 to 826       826/963
(85 %)
18 diff
(98.2 %id)
CT003485 T-Lymphocytes .g 120 to 975 1 to 857       857/858
(99 %)
4 diff
(99.6 %id)
BG034477 breast, mammary adenocarcinoma, cell line .g 121 to 912 1 to 783       783/785
(99 %)
14 diff
(98.3 %id)
CB143333 Liver .g 122 to 777 1 to 656       656/656
(100 %)
0 diff
(100 %id)
CB140857 Liver .g 126 to 724 1 to 599       599/599
(100 %)
0 diff
(100 %id)
BG741671 skin .g 127 to 878 1 to 753       753/753
(100 %)
1 diff
(99.9 %id)
BE298147 muscle, rhabdomyosarcoma .g 131 to 697 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BQ690151 ductal carcinoma, cell line, Pancreas .g 131 to 1010 1 to 890       890/891
(99 %)
14 diff
(98.5 %id)
DA511902 brain .g 136 to 693 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
CB159101 Liver .g 137 to 757 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BG743407 skin .g 140 to 867 1 to 728       728/728
(100 %)
2 diff
(99.8 %id)
CR590457 placenta .g 142 to 1319 1 to 1178 exact     1178/1178
(100 %)
0 diff
(100 %id)
BP374307 umbilical cord .g 143 to 724 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ054349 blood, natural killer cells, cell line .g 144 to 1077 1 to 943       943/994
(94 %)
19 diff
(98.1 %id)
BG677725 skin, squamous cell carcinoma .g 146 to 912 1 to 766       766/767
(99 %)
3 diff
(99.7 %id)
BG675254 skin .g 146 to 1062 1 to 915       915/915
(100 %)
14 diff
(98.5 %id)
BG697158 skin .g 146 to 924 1 to 778       778/778
(100 %)
1 diff
(99.9 %id)
BF794626 lymph, lymphoma, cell line .g 149 to 768 1 to 620       620/620
(100 %)
0 diff
(100 %id)
CB045040 colon, juvenile granulosa tumor .g 150 to 776 35 to 661       627/661
(94 %)
6 diff
(99.1 %id)
BG681709 skin, squamous cell carcinoma .g 151 to 1062 1 to 912       912/921
(99 %)
12 diff
(98.7 %id)
BQ052680 blood, natural killer cells, cell line .g 153 to 951 1 to 802       802/1034
(77 %)
14 diff
(98.7 %id)
BP307660 brain .g 156 to 747 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BG696041 skin .g 160 to 1080 1 to 932       932/937
(99 %)
7 diff
(99.3 %id)
BU168409 ductal carcinoma, cell line, Pancreas .g 161 to 940 1 to 787       787/1070
(73 %)
21 diff
(98.1 %id)
BQ691107 ductal carcinoma, cell line, Pancreas .g 161 to 1081 1 to 939       939/956
(98 %)
25 diff
(97.4 %id)
BU845295 ovary, teratocarcinoma, cell line .g 164 to 1030 1 to 876       876/882
(99 %)
13 diff
(98.6 %id)
BU553603 ovary, teratocarcinoma, cell line .g 164 to 1069 1 to 914       914/914
(100 %)
11 diff
(98.8 %id)
DA892642 salivary gland .g 168 to 902 2 to 736   fully sequenced, capped   735/735
(100 %)
1 diff
(99.9 %id)
DA897496 skeletal muscle .g 168 to 740 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
CB109823 Liver .g 170 to 696 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BG477715 melanotic melanoma, skin .g 172 to 1190 1 to 1025       1025/1035
(99 %)
54 diff
(94.8 %id)
BG476629 melanotic melanoma, skin .g 172 to 1040 1 to 865       865/866
(99 %)
8 diff
(99.1 %id)
CN346015 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 175 to 880 1 to 707       707/707
(100 %)
1 diff
(99.9 %id)
AL519569 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .g 176 to 898 1 to 723   fully sequenced,   723/723
(100 %)
0 diff
(100 %id)
BQ643366 lymph, lymphoma, cell line .g 178 to 1072 1 to 898       898/931
(96 %)
21 diff
(97.8 %id)
BX402464 Placenta Cot 25-normalized .g 185 to 1232 1 to 1036       1036/1049
(98 %)
17 diff
(98.4 %id)
BX398825 Placenta Cot 25-normalized .g 186 to 532 1 to 347   fully sequenced,   347/347
(100 %)
1 diff
(99.8 %id)
BM845274 myeloma .g 190 to 326 1 to 137       137/137
(100 %)
0 diff
(100 %id)
BJ995035 hepatoblastoma .g 191 to 790 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
DB487264 hypothalamus .g 193 to 634 1 to 442       442/442
(100 %)
0 diff
(100 %id)
DB500043 hypothalamus .g 193 to 670 1 to 478       478/478
(100 %)
0 diff
(100 %id)
BP281933 bone marrow .g 193 to 779 1 to 587       587/587
(100 %)
0 diff
(100 %id)
CR978189 T-Lymphocytes .g 196 to 1030 1 to 835       835/838
(99 %)
3 diff
(99.7 %id)
CN346014 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 198 to 746 1 to 549       549/549
(100 %)
0 diff
(100 %id)
TI_57229921   .g 198 to 1028 88 to 922       835/840
(99 %)
7 diff
(99.2 %id)
BM766928 stomach .g 201 to 758 1 to 558       558/558
(100 %)
0 diff
(100 %id)
BU661677 blood .g 202 to 878 1 to 677       677/677
(100 %)
0 diff
(100 %id)
BU521077 leiomyosarcoma, uterus .g 204 to 1046 39 to 886       848/886
(95 %)
19 diff
(97.9 %id)
TI_59380846   .g 204 to 1018 102 to 914       813/813
(100 %)
3 diff
(99.7 %id)
BU160879 melanotic melanoma, skin .g 208 to 1024 1 to 818       818/910
(89 %)
10 diff
(99.0 %id)
BI085647 astrocytoma grade IV, cell line, brain .g 209 to 736 1 to 530   fully sequenced,   530/530
(100 %)
3 diff
(99.5 %id)
TI_59389253   .g 209 to 1006 99 to 895       797/797
(100 %)
5 diff
(99.4 %id)
CB163805 Liver .g 209 to 752 1 to 544       544/544
(100 %)
0 diff
(100 %id)
TI_59390368   .g 210 to 982 103 to 877       775/775
(100 %)
5 diff
(99.4 %id)
TI_59390369   .g 210 to 985 98 to 873       776/776
(100 %)
8 diff
(99.0 %id)
BI334785 cervical carcinoma cell line, cervix .g 211 to 929 1 to 721       721/721
(100 %)
2 diff
(99.8 %id)
BM016634 astrocytoma grade IV, cell line, brain .g 211 to 1081 1 to 874       874/879
(99 %)
15 diff
(98.3 %id)
BQ643076 lymph, lymphoma, cell line .g 211 to 1134 1 to 925       925/932
(99 %)
17 diff
(98.2 %id)
BQ882873 lymph, lymphoma, cell line .g 211 to 868 1 to 659       659/970
(67 %)
6 diff
(99.4 %id)
BQ935972 large cell carcinoma, lung .g 211 to 1074 1 to 873       873/873
(100 %)
10 diff
(98.9 %id)
TI_59386840   .g 211 to 1081 104 to 977       874/879
(99 %)
15 diff
(98.3 %id)
CN346005 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 212 to 522 1 to 311       311/311
(100 %)
0 diff
(100 %id)
BQ883477 brain, neuroblastoma, cell line .g 212 to 1081 1 to 872       872/891
(97 %)
7 diff
(99.3 %id)
BG743906 blood, natural killer cells, cell line .g 213 to 532 1 to 320   fully sequenced,   320/320
(100 %)
0 diff
(100 %id)
BQ933069 large cell carcinoma, lung .g 213 to 1079 1 to 867       867/867
(100 %)
3 diff
(99.7 %id)
BQ924875 large cell carcinoma, lung .g 213 to 946 1 to 739       737/926
(79 %)
4 diff
(99.6 %id)
BM449563 melanotic melanoma, skin .g 214 to 1079 1 to 868       868/1090
(79 %)
13 diff
(98.9 %id)
BU540648 large cell carcinoma, lung .g 214 to 1027 1 to 821       821/896
(91 %)
10 diff
(98.9 %id)
J05262   .g 214 to 1337 1 to 1124 I116T AAA   1124/1124
(100 %)
2 diff
(99.9 %id)
CN346027 embryonic stem cells, DMSO-treated H9 cellline .g 215 to 701 1 to 487       487/487
(100 %)
0 diff
(100 %id)
BF312567 brain, neuroblastoma .g 216 to 946 7 to 739       733/984
(74 %)
16 diff
(98.4 %id)
BG774009 choriocarcinoma, placenta .g 216 to 974 7 to 765       759/765
(99 %)
6 diff
(99.3 %id)
BE741495 adenocarcinoma cell line, ovary .g 217 to 915 1 to 700       700/700
(100 %)
1 diff
(99.9 %id)
BG473101 eye, retinoblastoma .g 218 to 892 1 to 675       675/675
(100 %)
0 diff
(100 %id)
BE270198 Burkitt lymphoma, lymph .g 220 to 845 1 to 626       626/627
(99 %)
1 diff
(99.9 %id)
BE746682 adenocarcinoma cell line, ovary .g 221 to 1033 1 to 812       812/921
(88 %)
23 diff
(97.6 %id)
CB119298 Liver .g 224 to 715 1 to 492       492/492
(100 %)
0 diff
(100 %id)
CB154126 Liver .g 224 to 847 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BG696712 skin .g 225 to 1075 1 to 850       850/851
(99 %)
5 diff
(99.5 %id)
BU930903 ovary, teratocarcinoma, cell line .g 227 to 951 1 to 730       730/912
(80 %)
7 diff
(99.3 %id)
BE279541 choriocarcinoma, placenta .g 230 to 907 1 to 674       674/689
(97 %)
8 diff
(98.9 %id)
BX386104 Placenta Cot 25-normalized .g 236 to 1303 1063 to 1       1063/1063
(100 %)
7 diff
(99.4 %id)
CB106996 Liver .g 240 to 700 1 to 461       461/461
(100 %)
0 diff
(100 %id)
M29863   .g 240 to 1337 1 to 1098   tiling clone,   1098/1098
(100 %)
0 diff
(100 %id)
CN346028 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g 243 to 927 1 to 685       685/685
(100 %)
0 diff
(100 %id)
CN346030 embryonic stem cells, cell lines H1, H7, andH9 .g 243 to 902 1 to 660       660/660
(100 %)
0 diff
(100 %id)
BE900345 choriocarcinoma, placenta .g 244 to 888 1 to 645       645/645
(100 %)
0 diff
(100 %id)
BE407651 choriocarcinoma, placenta .g 246 to 849 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BU856393 ovary, teratocarcinoma, cell line .g 262 to 1023 1 to 767       767/883
(86 %)
6 diff
(99.4 %id)
BU856435 ovary, teratocarcinoma, cell line .g 262 to 940 1 to 684       684/840
(81 %)
8 diff
(99.1 %id)
BM826634 Ascites, stomach .g 266 to 869 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BU553923 ovary, teratocarcinoma, cell line .g 272 to 1142 1 to 875       875/878
(99 %)
6 diff
(99.4 %id)
BM853396 Ascites, stomach .g 314 to 697 1 to 384       384/384
(100 %)
0 diff
(100 %id)
BE378103 endometrium, adenocarcinoma cell line, uterus .g 383 to 910 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BQ877587 melanotic melanoma, cell line, skin .g 399 to 1303 1 to 910       910/913
(99 %)
13 diff
(98.6 %id)
BQ676720 melanotic melanoma, cell line, skin .g 399 to 666 1 to 268       268/268
(100 %)
0 diff
(100 %id)
BQ949227 large cell carcinoma, lung .g 399 to 1304 1 to 914       914/916
(99 %)
19 diff
(98.0 %id)
BU539056 adenocarcinoma, cell line, breast .g 413 to 1277 1 to 869       869/972
(89 %)
23 diff
(97.7 %id)
BU956249 adenocarcinoma, cell line, breast .g 413 to 1276 1 to 868       868/868
(100 %)
11 diff
(98.8 %id)
BU956585 adenocarcinoma, cell line, breast .g 413 to 1277 1 to 868       868/888
(97 %)
9 diff
(99.0 %id)
BQ216236 embryonal carcinoma, cell line, testis .g 434 to 745 1 to 312       312/316
(98 %)
1 diff
(99.7 %id)
BX342625   .g 450 to 1334 1 to 884   fully sequenced,   884/884
(100 %)
2 diff
(99.8 %id)
BX398824 Placenta Cot 25-normalized .g 471 to 1309 838 to 1   fully sequenced,   838/838
(100 %)
5 diff
(99.5 %id)
BX342624   .g 471 to 1299 831 to 4   fully sequenced,   828/831
(99 %)
0 diff
(100 %id)
BG744592 blood, natural killer cells, cell line .g 476 to 1286 811 to 1   fully sequenced,   811/811
(100 %)
8 diff
(99.1 %id)
CN346020 embryonic stem cells, DMSO-treated H9 cellline .g 478 to 976 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BQ440262 melanotic melanoma, skin .g 510 to 1342 1 to 835       835/837
(99 %)
6 diff
(99.3 %id)
TI_149300219   .g 511 to 1337 916 to 98   AAA   819/917
(89 %)
13 diff
(98.6 %id)
TI_149315701   .g 511 to 1337 902 to 82   AAA   821/987
(83 %)
7 diff
(99.3 %id)
TI_154015699   .g 512 to 1337 916 to 94   AAA   823/1003
(82 %)
10 diff
(99.1 %id)
TI_149310040   .g 541 to 1337 877 to 84   AAA   794/951
(83 %)
9 diff
(99.1 %id)
TI_149306335   .g 566 to 1337 855 to 88   AAA   768/977
(78 %)
12 diff
(98.8 %id)
CB528984 Aveolar Macrophage, lung .g 586 to 1337 770 to 19   AAA   752/753
(99 %)
0 diff
(100 %id)
BQ682430 melanotic melanoma, cell line, skin .g 608 to 1338 1 to 735   AAA   735/735
(100 %)
7 diff
(99.1 %id)
BU194689 melanotic melanoma, cell line, skin .g 608 to 1313 1 to 711       711/888
(80 %)
5 diff
(99.5 %id)
BQ877451 melanotic melanoma, cell line, skin .g 609 to 1337 1 to 731   AAA   731/731
(100 %)
4 diff
(99.5 %id)
BU838773 melanotic melanoma, cell line, skin .g 609 to 1337 1 to 735       735/883
(83 %)
15 diff
(98.4 %id)
TI_154128574   .g 628 to 1337 806 to 100   AAA   707/707
(100 %)
3 diff
(99.6 %id)
TI_149292810   .g 640 to 1337 781 to 85   AAA   697/697
(100 %)
3 diff
(99.6 %id)
CB110271 Liver .g 655 to 1284 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BI861820 breast, mammary adenocarcinoma, cell line .g 659 to 1337 1 to 679       679/697
(97 %)
1 diff
(99.9 %id)
TI_149291821   .g 660 to 1337 763 to 88   AAA   676/676
(100 %)
4 diff
(99.5 %id)
CB306485 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 661 to 1337 695 to 19   AAA   677/677
(100 %)
0 diff
(100 %id)
BI086125 astrocytoma grade IV, cell line, brain .g 675 to 1289 617 to 1   fully sequenced,   617/617
(100 %)
12 diff
(98.1 %id)
CA437017 lung, Metastatic Chondrosarcoma .g 681 to 1337 675 to 19   AAA   657/657
(100 %)
0 diff
(100 %id)
BU686382 lung, Primary Lung Epithelial Cells .g 683 to 1337 673 to 19   AAA   655/655
(100 %)
0 diff
(100 %id)
BM976337 lung, Primary Lung Cystic Fibrosis EpithelialCells .g 683 to 1337 673 to 19   AAA   655/655
(100 %)
0 diff
(100 %id)
BU688384 lung .g 684 to 1337 672 to 19   AAA   654/654
(100 %)
0 diff
(100 %id)
BU630332 cell lines, Chondrosarcoma .g 689 to 1337 667 to 19   AAA   649/649
(100 %)
0 diff
(100 %id)
CA309571 Alveolar Macrophage, lung .g 689 to 1337 666 to 19   AAA   648/648
(100 %)
1 diff
(99.9 %id)
BU682147 lung .g 698 to 1337 657 to 19   AAA   639/639
(100 %)
3 diff
(99.6 %id)
BM974868 lung .g 698 to 1337 658 to 19   AAA   640/640
(100 %)
0 diff
(100 %id)
BU629384 cell lines, Chondrosarcoma .g 701 to 1337 655 to 19   AAA   637/637
(100 %)
6 diff
(99.1 %id)
CB528990 Aveolar Macrophage, lung .g 704 to 1338 652 to 19   AAA   634/640
(99 %)
4 diff
(99.4 %id)
BP422943 small intestine .g 721 to 1218 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
CB157692 Liver .g 721 to 1123 1 to 403       403/403
(100 %)
0 diff
(100 %id)
CA428103 Bone, Subchondral Bone .g 738 to 1337 618 to 19   AAA   600/600
(100 %)
0 diff
(100 %id)
BU630656 cell lines, Chondrosarcoma .g 758 to 1337 598 to 19   AAA   580/580
(100 %)
0 diff
(100 %id)
BQ681363 melanotic melanoma, cell line, skin .g 767 to 1337 1 to 571       571/571
(100 %)
0 diff
(100 %id)
BU931981 ovary, teratocarcinoma, cell line .g 769 to 1337 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BX394245 Neuroblastoma Cot 25-normalized .g 793 to 1338 1 to 546       546/546
(100 %)
0 diff
(100 %id)
BF768375 epid_tumor .g 801 to 1240 448 to 9     Submitted on the opposite strand 440/448
(98 %)
0 diff
(100 %id)
EC516541 Prostate .g 802 to 895 1 to 94       94/94
(100 %)
0 diff
(100 %id)
AV702437 adrenal gland .g 808 to 1337 1 to 530   AAA   530/530
(100 %)
0 diff
(100 %id)
EC536958 Prostate .g 809 to 899 1 to 91       91/91
(100 %)
0 diff
(100 %id)
AI742979 pooled .g 822 to 1337 526 to 11   AAA   516/516
(100 %)
0 diff
(100 %id)
BJ995036 hepatoblastoma .g 829 to 1301 473 to 1       473/473
(100 %)
0 diff
(100 %id)
AW250912 lung, small cell carcinoma .g 830 to 1337 518 to 11   AAA   508/508
(100 %)
0 diff
(100 %id)
BE874449 large cell carcinoma, undifferentiated, lung .g 834 to 1337 1 to 504   AAA   504/504
(100 %)
0 diff
(100 %id)
AL519568 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .g 837 to 1310 472 to 1   fully sequenced,   472/472
(100 %)
6 diff
(98.8 %id)
CA417637 Chondrosarcoma Cell line .g 841 to 1337 515 to 19   AAA   497/497
(100 %)
0 diff
(100 %id)
DB330580 salivary gland .g 845 to 1337 497 to 1   fully sequenced,   497/497
(100 %)
5 diff
(99.0 %id)
BU556935 ovary, teratocarcinoma, cell line .g 856 to 1338 1 to 483   AAA   483/483
(100 %)
0 diff
(100 %id)
CB045039 colon, juvenile granulosa tumor .g 858 to 1337 497 to 18   AAA   480/480
(100 %)
0 diff
(100 %id)
DR979862 placenta .g 865 to 1077 1 to 212   AAA Submitted on the opposite strand 212/212
(100 %)
3 diff
(98.6 %id)
DR979872 placenta .g 865 to 1045 1 to 180   AAA Submitted on the opposite strand 180/180
(100 %)
3 diff
(98.4 %id)
DB568005 hypothalamus .g 877 to 1337 1 to 461   AAA Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
BE539630 cervix .g 879 to 1332 1 to 454       454/454
(100 %)
0 diff
(100 %id)
AI131343 heart .g 880 to 1337 458 to 1       458/458
(100 %)
0 diff
(100 %id)
BM696768 eye, lens .g 881 to 1337 1 to 457   fully sequenced, AAA   457/457
(100 %)
0 diff
(100 %id)
DB573830 hypothalamus .g 883 to 1335 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
AI050803 Kidney .g 889 to 1337 459 to 11   AAA   449/449
(100 %)
0 diff
(100 %id)
BQ786892 Pancreas, Purified pancreatic islet .g 896 to 1337 444 to 3       442/444
(99 %)
0 diff
(100 %id)
DB558909 hypothalamus .g 898 to 1337 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AW474539 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 919 to 1337 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AI687102 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .g 923 to 1337 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AW474457 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 949 to 1337 389 to 1       389/389
(100 %)
0 diff
(100 %id)
AW732034 lung, small cell carcinoma .g 966 to 1337 387 to 16   AAA   372/372
(100 %)
0 diff
(100 %id)
AW771094 colon, juvenile granulosa tumor .g 999 to 1337 339 to 1       339/339
(100 %)
0 diff
(100 %id)
BE047993 brain, tumor, 5 pooled (see description) .g 1011 to 1338 1 to 328   AAA   328/328
(100 %)
0 diff
(100 %id)
AV707462 adrenal gland .g 1019 to 1339 1 to 321   AAA   321/321
(100 %)
0 diff
(100 %id)
BM012980 brain, neuroblastoma, cell line .g 1032 to 1337 1 to 306   AAA   306/306
(100 %)
0 diff
(100 %id)
BG231050 nasopharynx, normal epithelium .g 1038 to 1337 324 to 25   AAA   300/300
(100 %)
0 diff
(100 %id)
EC489957 Prostate .g 1044 to 1147 1 to 104       104/104
(100 %)
0 diff
(100 %id)
EC524020 Prostate .g 1044 to 1147 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BU735282 eye, lens .g 1050 to 1337 306 to 19   fully sequenced, AAA   288/288
(100 %)
0 diff
(100 %id)
BX366034 Neuroblastoma Cot 25-normalized .g 1085 to 1337 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BX374950 Neuroblastoma Cot 25-normalized .g 1085 to 1337 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BU186375 large cell carcinoma, lung .g 1127 to 1337 1 to 211   AAA   211/211
(100 %)
0 diff
(100 %id)
AI304609 adenocarcinoma, colon .g 1171 to 1337 167 to 1       167/167
(100 %)
0 diff
(100 %id)
CB124861 Liver .g 1194 to 1332 1 to 139       139/139
(100 %)
0 diff
(100 %id)
EC554586 Prostate .g 1239 to 1333 1 to 95       95/95
(100 %)
0 diff
(100 %id)
DR760759 embryonic stem .h 1 to 810 6 to 814   tiling clone,   814/814
(100 %)
0 diff
(100 %id)
CB144418 Liver .h 5 to 637 1 to 633       633/633
(100 %)
0 diff
(100 %id)
BP195489 brain .h 13 to 595 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CB141943 Liver .h 13 to 377 1 to 365       365/365
(100 %)
0 diff
(100 %id)
DA075058 cerebellum .h 14 to 575 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA665646   .h 14 to 559 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DT214993 brain .h 15 to 648 1 to 634       634/643
(98 %)
2 diff
(99.7 %id)
BP231367 muscle .h 15 to 596 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP308678 brain .h 15 to 606 1 to 592       592/592
(100 %)
0 diff
(100 %id)
CB129640 Liver .h 24 to 382 1 to 359       359/359
(100 %)
0 diff
(100 %id)
BQ072101 brain, neuroblastoma, cell line .h 27 to 1019 22 to 1017       996/1035
(96 %)
23 diff
(97.8 %id)
BP328398 rectum .h 27 to 608 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CN401901 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 28 to 262 1 to 235       235/235
(100 %)
0 diff
(100 %id)
BQ918829 brain, neuroblastoma, cell line .h 31 to 960 1 to 932       934/944
(98 %)
25 diff
(97.4 %id)
BU168838 ductal carcinoma, cell line, Pancreas .h 32 to 894 31 to 895       865/928
(93 %)
14 diff
(98.5 %id)
CF595713 Stomach, adenocarcinoma .h 32 to 863 1 to 835       835/836
(99 %)
8 diff
(99.1 %id)
TI_59394894   .h 32 to 524 133 to 633   AAA   501/1035
(48 %)
11 diff
(99.0 %id)
BG327079 Kidney, renal cell adenocarcinoma .h 33 to 699 1 to 667       667/667
(100 %)
0 diff
(100 %id)
BQ688167 ductal carcinoma, cell line, Pancreas .h 34 to 977 1 to 947       947/948
(99 %)
13 diff
(98.7 %id)
BQ691776 ductal carcinoma, cell line, Pancreas .h 34 to 961 1 to 930       930/948
(98 %)
15 diff
(98.5 %id)
BQ889906 brain, neuroblastoma, cell line .h 35 to 919 21 to 912       892/912
(97 %)
18 diff
(98.1 %id)
CR987467 T-Lymphocytes .h 36 to 947 1 to 915       915/915
(100 %)
6 diff
(99.4 %id)
BQ069914 brain, neuroblastoma, cell line .h 37 to 1015 18 to 999       982/1024
(95 %)
25 diff
(97.6 %id)
TI_59389033   .h 37 to 648 107 to 735       604/701
(86 %)
21 diff
(97.1 %id)
BG765639 melanotic melanoma, high MDR (cell line), skin .h 39 to 923 1 to 883       883/886
(99 %)
14 diff
(98.5 %id)
TI_59381545   .h 39 to 645 65 to 671       607/609
(99 %)
2 diff
(99.7 %id)
CR992760 T-Lymphocytes .h 39 to 918 1 to 885       885/895
(98 %)
7 diff
(99.3 %id)
BM456542 lymph, lymphoma, cell line .h 40 to 894 1 to 858       858/1006
(85 %)
8 diff
(99.3 %id)
CX787384 human embryonic stem cells .h 40 to 879 1 to 840       840/840
(100 %)
0 diff
(100 %id)
DB011729 esophageal, tumor tissue .h 40 to 588 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BU159251 epithelioid carcinoma, Pancreas .h 41 to 883 1 to 851       851/855
(99 %)
24 diff
(97.2 %id)
BU857458 adenocarcinoma, cell line, breast .h 42 to 878 1 to 842       842/898
(93 %)
15 diff
(98.4 %id)
BI257903 cervical carcinoma cell line, cervix .h 43 to 912 1 to 865       865/868
(99 %)
7 diff
(99.2 %id)
BU553635 ovary, teratocarcinoma, cell line .h 43 to 938 1 to 897       897/901
(99 %)
8 diff
(99.2 %id)
AU135293 placenta .h 44 to 739 2 to 699   capped   696/763
(91 %)
18 diff
(97.7 %id)
BE795822 lung, small cell carcinoma .h 47 to 889 1 to 845       845/912
(92 %)
24 diff
(97.4 %id)
BG697322 skin .h 47 to 927 1 to 883       883/883
(100 %)
8 diff
(99.1 %id)
BP340053 Spleen .h 48 to 627 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BE743399 adenocarcinoma cell line, ovary .h 49 to 873 1 to 818       818/1076
(76 %)
12 diff
(98.9 %id)
BG740898 skin .h 49 to 847 1 to 800       800/800
(100 %)
3 diff
(99.7 %id)
DR760719 embryonic stem .h 49 to 873 1 to 825       825/825
(100 %)
0 diff
(100 %id)
DR760736 embryonic stem .h 49 to 806 1 to 758       758/758
(100 %)
0 diff
(100 %id)
BI226298 Burkitt lymphoma, lymph .h 50 to 737 1 to 689       689/827
(83 %)
7 diff
(99.2 %id)
BU196946 ductal carcinoma, cell line, Pancreas .h 51 to 936 1 to 892       892/971
(91 %)
19 diff
(98.1 %id)
BQ686185 ductal carcinoma, cell line, Pancreas .h 51 to 889 1 to 846       846/886
(95 %)
9 diff
(99.0 %id)
BQ878200 ductal carcinoma, cell line, Pancreas .h 51 to 815 1 to 765       765/837
(91 %)
5 diff
(99.5 %id)
CB138402 Liver .h 52 to 667 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BG750128 eye, normal pigmented retinal epithelium .h 54 to 972 1 to 914       915/943
(97 %)
17 diff
(98.2 %id)
BG697666 skin .h 56 to 916 1 to 869       869/869
(100 %)
12 diff
(98.7 %id)
BM048826 carcinoma, cell line, Prostate .h 57 to 894 1 to 849       849/971
(87 %)
25 diff
(97.5 %id)
CB143905 Liver .h 58 to 454 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BG114004 Bone, osteosarcoma, cell line .h 60 to 876 1 to 805       805/1004
(80 %)
24 diff
(97.7 %id)
BG684786 B-cells, primary B-cells from tonsils (cell line) .h 60 to 866 1 to 811       811/811
(100 %)
15 diff
(98.2 %id)
BG696284 skin .h 60 to 917 1 to 862       862/864
(99 %)
9 diff
(99.0 %id)
BQ941435 epidermoid carcinoma, cell line, lung .h 60 to 878 1 to 821       821/943
(87 %)
10 diff
(99.0 %id)
BQ920070 carcinoma, cell line, Prostate .h 60 to 1002 1 to 950       950/950
(100 %)
15 diff
(98.5 %id)
BU543031 carcinoma, cell line, Prostate .h 60 to 815 1 to 758       758/889
(85 %)
8 diff
(99.2 %id)
DR157013 human embryonic stem cells differentiated toan early endodermal cell type .h 61 to 890 1 to 830       830/830
(100 %)
0 diff
(100 %id)
BX360228 Placenta Cot 25-normalized .h 62 to 475 1 to 413   fully sequenced,   413/413
(100 %)
3 diff
(99.3 %id)
BQ686024 ductal carcinoma, cell line, Pancreas .h 63 to 808 1 to 749       749/892
(83 %)
4 diff
(99.6 %id)
BQ935538 large cell carcinoma, lung .h 63 to 815 1 to 761       761/952
(79 %)
13 diff
(98.7 %id)
BP208327 cerebellum .h 65 to 648 1 to 584       584/585
(99 %)
0 diff
(100 %id)
AU076552 colon mucosa .h 65 to 212 1 to 148       148/148
(100 %)
0 diff
(100 %id)
TI_57176599   .h 65 to 654 11 to 609   AAA   599/652
(91 %)
23 diff
(96.5 %id)
BQ064255 lymph, lymphoma, cell line .h 66 to 963 1 to 906       906/997
(90 %)
12 diff
(98.8 %id)
BU190946 ductal carcinoma, cell line, Pancreas .h 66 to 871 1 to 818       818/893
(91 %)
16 diff
(98.3 %id)
BU185833 ductal carcinoma, cell line, Pancreas .h 66 to 880 1 to 816       816/906
(90 %)
11 diff
(98.8 %id)
BQ880818 ductal carcinoma, cell line, Pancreas .h 66 to 938 1 to 878       878/879
(99 %)
7 diff
(99.3 %id)
BQ642474 lymph, lymphoma, cell line .h 66 to 959 1 to 893       893/970
(92 %)
20 diff
(98.0 %id)
BF794249 lymph, lymphoma, cell line .h 68 to 807 1 to 747       747/1148
(65 %)
10 diff
(99.2 %id)
BQ430140 epithelioid carcinoma, Pancreas .h 69 to 955 1 to 890       889/890
(99 %)
13 diff
(98.6 %id)
CR975508 T-Lymphocytes .h 69 to 837 1 to 771       771/773
(99 %)
4 diff
(99.5 %id)
BF974371 B-cells, primary B-cells from tonsils (cell line) .h 70 to 957 1 to 901       901/951
(94 %)
30 diff
(96.9 %id)
BU844867 ovary, teratocarcinoma, cell line .h 70 to 960 1 to 897       897/897
(100 %)
9 diff
(99.0 %id)
BQ053766 blood, natural killer cells, cell line .h 72 to 1018 1 to 951       951/1001
(95 %)
25 diff
(97.6 %id)
BE253611 eye, retinoblastoma .h 75 to 811 1 to 737       737/875
(84 %)
2 diff
(99.8 %id)
BE884479 leiomyosarcoma, uterus .h 78 to 698 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BG757837 B-cells, primary B-cells from tonsils (cell line) .h 79 to 969 1 to 887       887/949
(93 %)
31 diff
(96.8 %id)
BM045726 carcinoma, cell line, Prostate .h 80 to 920 1 to 845       845/845
(100 %)
7 diff
(99.2 %id)
CB158909 Liver .h 81 to 733 1 to 653       653/653
(100 %)
0 diff
(100 %id)
CR988512 T-Lymphocytes .h 81 to 792 1 to 712       712/714
(99 %)
1 diff
(99.9 %id)
BP196796 adrenal gland .h 83 to 663 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BQ944010 carcinoma, cell line, Prostate .h 83 to 1024 1 to 947       947/950
(99 %)
20 diff
(97.9 %id)
DW454874 Liver .h 89 to 249 18 to 178       161/178
(90 %)
12 diff
(93.3 %id)
BQ894303 Spleen .h 94 to 879 1 to 789       789/889
(88 %)
6 diff
(99.4 %id)
CN401885 embryonic stem cells, DMSO-treated H9 cellline .h 96 to 810 6 to 719       714/719
(99 %)
6 diff
(99.2 %id)
BI092666 cervix .h 98 to 874 1 to 777       777/817
(95 %)
9 diff
(98.9 %id)
BQ058910 lymph, lymphoma, cell line .h 99 to 1022 1 to 929   AAA   929/959
(96 %)
20 diff
(98.0 %id)
BQ065149 lymph, lymphoma, cell line .h 99 to 889 1 to 794       794/1023
(77 %)
9 diff
(99.2 %id)
BQ065158 lymph, lymphoma, cell line .h 99 to 966 1 to 877       877/986
(88 %)
12 diff
(98.8 %id)
BQ066552 lymph, lymphoma, cell line .h 99 to 1024 1 to 931       931/1023
(91 %)
17 diff
(98.4 %id)
BQ642083 lymph, lymphoma, cell line .h 99 to 1024 1 to 931       931/939
(99 %)
22 diff
(97.7 %id)
BQ064901 lymph, lymphoma, cell line .h 100 to 966 1 to 873       873/987
(88 %)
13 diff
(98.7 %id)
BQ071273 brain, neuroblastoma, cell line .h 101 to 962 1 to 866       866/969
(89 %)
6 diff
(99.4 %id)
CA489635   .h 101 to 963 1 to 873       873/902
(96 %)
14 diff
(98.5 %id)
AL521209 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .h 107 to 475 1 to 369   fully sequenced,   369/369
(100 %)
0 diff
(100 %id)
CA394096 eye, RPE/choroid .h 107 to 760 1 to 654       654/654
(100 %)
0 diff
(100 %id)
EC483750 Prostate .h 108 to 195 19 to 101       85/105
(80 %)
9 diff
(91.5 %id)
BG389401 embryonal carcinoma, cell line, testis .h 108 to 963 1 to 851       853/882
(96 %)
29 diff
(96.8 %id)
BP871357 embryonal kidney .h 112 to 443 1 to 332       332/332
(100 %)
0 diff
(100 %id)
CB142677 Liver .h 112 to 658 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DT215776 brain .h 115 to 545 1 to 431       431/431
(100 %)
0 diff
(100 %id)
TI_57240025   .h 115 to 889 27 to 800       774/836
(92 %)
11 diff
(98.7 %id)
CB110075 Liver .h 115 to 673 1 to 559       559/559
(100 %)
0 diff
(100 %id)
CB114001 Liver .h 115 to 645 1 to 531       531/531
(100 %)
0 diff
(100 %id)
CB119090 Liver .h 115 to 567 1 to 453       453/453
(100 %)
0 diff
(100 %id)
CN401884 embryonic stem cells, DMSO-treated H9 cellline .h 118 to 733 1 to 616       616/616
(100 %)
0 diff
(100 %id)
CR985165 T-Lymphocytes .h 118 to 859 1 to 743       743/743
(100 %)
2 diff
(99.8 %id)
BQ061728 lymph, lymphoma, cell line .h 120 to 964 1 to 847       847/970
(87 %)
7 diff
(99.3 %id)
BQ064080 lymph, lymphoma, cell line .h 120 to 1012 1 to 901       901/964
(93 %)
15 diff
(98.5 %id)
BQ066197 lymph, lymphoma, cell line .h 120 to 1022 1 to 913       913/993
(91 %)
21 diff
(97.9 %id)
BQ066601 lymph, lymphoma, cell line .h 120 to 1024 1 to 913       913/1020
(89 %)
12 diff
(98.9 %id)
BQ642378 lymph, lymphoma, cell line .h 120 to 963 1 to 845       845/939
(89 %)
7 diff
(99.3 %id)
TI_59381053   .h 120 to 864 97 to 840       744/748
(99 %)
13 diff
(98.3 %id)
BG577339 breast, mammary adenocarcinoma, cell line .h 121 to 1065 1 to 826       778/828
(93 %)
23 diff
(97.3 %id)
CB122746 Liver .h 122 to 519 1 to 398       398/398
(100 %)
0 diff
(100 %id)
AU126095   .h 123 to 889 2 to 768   capped   767/799
(95 %)
10 diff
(98.8 %id)
AU129049   .h 124 to 781 2 to 664   fully sequenced, capped   663/663
(100 %)
9 diff
(98.7 %id)
BE747929 adenocarcinoma cell line, ovary .h 126 to 876 37 to 784       748/784
(95 %)
3 diff
(99.7 %id)
BC015653 Placenta, choriocarcinoma .h 126 to 1280 450 to 1604 exact tiling clone, AAA   1155/1577
(73 %)
6 diff
(99.7 %id)
BQ653627 hepatocellular carcinoma, cell line, Liver .h 126 to 1012 13 to 904       892/908
(98 %)
13 diff
(98.6 %id)
BQ650947 hepatocellular carcinoma, cell line, Liver .h 126 to 1024 15 to 921       907/990
(91 %)
24 diff
(97.6 %id)
BU151518 brain, neuroblastoma, cell line .h 128 to 1023 1 to 900       900/900
(100 %)
14 diff
(98.5 %id)
CN401887 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 131 to 781 1 to 652       652/652
(100 %)
1 diff
(99.9 %id)
BG697756 skin .h 131 to 959 1 to 826       826/828
(99 %)
5 diff
(99.4 %id)
BM710922 eye, fetal eyes .h 131 to 693 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
AW406006 lymph .h 133 to 545 7 to 419       413/419
(98 %)
0 diff
(100 %id)
BI861958 breast, mammary adenocarcinoma, cell line .h 133 to 1017 1 to 891       891/914
(97 %)
32 diff
(96.5 %id)
TI_57193544   .h 133 to 1017 27 to 917       891/914
(97 %)
32 diff
(96.5 %id)
TI_154143463   .h 133 to 738 79 to 683       605/725
(83 %)
10 diff
(98.7 %id)
BQ070594 brain, neuroblastoma, cell line .h 134 to 889 1 to 758       758/1055
(71 %)
3 diff
(99.8 %id)
DR156749 human embryonic stem cells differentiated toan early endodermal cell type .h 136 to 944 1 to 809       809/809
(100 %)
0 diff
(100 %id)
CX788924 human embryonic stem cells .h 138 to 946 1 to 809       809/809
(100 %)
0 diff
(100 %id)
CR625993 neuroblastoma .h 139 to 1249 1 to 1111 exact     1111/1111
(100 %)
0 diff
(100 %id)
AL521208 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .h 414 to 1252 839 to 1   fully sequenced,   839/839
(100 %)
8 diff
(99.1 %id)
BX360227 Placenta Cot 25-normalized .h 414 to 1252 839 to 1   fully sequenced,   839/839
(100 %)
4 diff
(99.6 %id)
TI_59394895   .h 526 to 1214 708 to 13       691/805
(85 %)
21 diff
(97.4 %id)
BM666022 eye, fetal eyes .h 716 to 1280 583 to 19   AAA   565/565
(100 %)
2 diff
(99.7 %id)
AU155951 placenta .h 747 to 1280 536 to 1       536/536
(100 %)
7 diff
(98.7 %id)
AU151233   .h 751 to 1281 533 to 1   fully sequenced,   533/533
(100 %)
6 diff
(98.9 %id)
DW418778 Liver .i 1 to 400 17 to 416   tiling clone,   407/416
(97 %)
7 diff
(98.4 %id)
BP248555 Kidney .i 1 to 579 5 to 583   tiling clone,   583/583
(100 %)
1 diff
(99.9 %id)
BQ220888 melanotic melanoma, skin .i 420 to 1094 1 to 675   tiling clone, AAA   675/675
(100 %)
6 diff
(99.2 %id)
AI830704 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .i 441 to 1094 659 to 8   tiling clone,   652/659
(98 %)
6 diff
(99.1 %id)
BG029797 breast, mammary adenocarcinoma, cell line .i 481 to 1094 1 to 611   AAA   611/611
(100 %)
9 diff
(98.6 %id)
BE383163 brain, neuroblastoma .j 1 to 685 6 to 691   tiling clone,   691/732
(94 %)
5 diff
(99.4 %id)
CB128814 Liver .j 8 to 612 1 to 604       604/604
(100 %)
0 diff
(100 %id)
CB116897 Liver .j 8 to 556 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
BQ877060 epidermoid carcinoma, cell line, lung .j 102 to 1014 1 to 919 N6H K255E Q269P I282N E283G ... tiling clone,   919/920
(99 %)
18 diff
(98.1 %id)
DW451345 Liver .k 1 to 365 14 to 378       365/378
(96 %)
7 diff
(98.2 %id)
CD675633 eye, lens .k 3 to 626 1 to 624   tiling clone,   624/624
(100 %)
0 diff
(100 %id)
CB144398 Liver .k 19 to 657 1 to 639       639/639
(100 %)
0 diff
(100 %id)
CR981281 T-Lymphocytes .k 68 to 814 1 to 749       749/749
(100 %)
2 diff
(99.8 %id)
BU956449 adenocarcinoma, cell line, breast .k 71 to 932 1 to 870   tiling clone,   870/897
(96 %)
16 diff
(98.3 %id)
BY995835   .k 111 to 832 11 to 732   tiling clone,   722/732
(98 %)
6 diff
(99.2 %id)
BM917998 blood, natural killer cells, cell line .l 1 to 879 1 to 881 L235C L236W E237K E240K Q245X ... tiling clone,   881/1014
(86 %)
19 diff
(98.2 %id)
BG251490 adenocarcinoma, cell line, Liver .l 100 to 880 1 to 774   tiling clone,   774/974
(79 %)
23 diff
(97.7 %id)
DA454911 tongue, tumor tissue .m 1 to 567 2 to 568   tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BM564254 blood, natural killer cells, cell line .m 9 to 769 1 to 767       767/1190
(64 %)
8 diff
(99.4 %id)
BU149669 ductal carcinoma, cell line, Pancreas .m 15 to 769 1 to 761       761/901
(84 %)
15 diff
(98.4 %id)
BQ878192 ductal carcinoma, cell line, Pancreas .m 15 to 883 1 to 869 K282X A285X K288Q tiling clone,   869/869
(100 %)
1 diff
(99.9 %id)
BQ690402 ductal carcinoma, cell line, Pancreas .m 15 to 841 1 to 836       812/958
(84 %)
16 diff
(98.4 %id)
BQ684719 ductal carcinoma, cell line, Pancreas .m 15 to 851 1 to 849       847/915
(92 %)
20 diff
(97.9 %id)
BQ688580 ductal carcinoma, cell line, Pancreas .m 15 to 745 1 to 735       735/934
(78 %)
14 diff
(98.6 %id)
BQ688616 ductal carcinoma, cell line, Pancreas .m 15 to 681 1 to 682       682/967
(70 %)
13 diff
(98.7 %id)
BQ685923 ductal carcinoma, cell line, Pancreas .m 17 to 842 1 to 838       838/875
(95 %)
14 diff
(98.4 %id)
BQ687702 ductal carcinoma, cell line, Pancreas .m 17 to 872 1 to 859       859/859
(100 %)
4 diff
(99.6 %id)
BG706014 brain, hypothalamus .n 1 to 793 5 to 793   tiling clone,   793/794
(99 %)
19 diff
(97.7 %id)
BI602585 brain, hypothalamus .n 1 to 865 5 to 864       864/909
(95 %)
32 diff
(96.5 %id)
DB489407 hypothalamus .n 2 to 467 1 to 468       468/468
(100 %)
13 diff
(97.3 %id)
TI_45213509   .n 2 to 865 90 to 948       859/993
(86 %)
33 diff
(96.7 %id)
BG939208 Bone, Hip .n 44 to 683 9 to 648       640/648
(98 %)
6 diff
(99.1 %id)
BU538903 adenocarcinoma, cell line, breast .n 46 to 650 1 to 607   AAA   607/888
(68 %)
5 diff
(99.5 %id)
BU844835 ovary, teratocarcinoma, cell line .n 48 to 913 1 to 866 K257X tiling clone,   866/866
(100 %)
0 diff
(100 %id)
BU856034 ovary, teratocarcinoma, cell line .n 51 to 864 30 to 850       821/933
(87 %)
18 diff
(98.1 %id)
BP195574 brain .n 63 to 644 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
CN346007 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 82 to 749 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
CN346017 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .o -10 to 236 5 to 252   tiling clone,   248/252
(98 %)
6 diff
(97.7 %id)
BM789417 Ascites, stomach .o 3 to 557 1 to 555   tiling clone,   555/555
(100 %)
1 diff
(99.9 %id)
BG423164 Kidney, renal cell adenocarcinoma .o 126 to 844 1 to 720   tiling clone,   720/934
(77 %)
17 diff
(98.2 %id)
BG385438 adenocarcinoma cell line, colon .p 1 to 732 1 to 732 D8G V9C Y10L A11C Q12P ... tiling clone,   732/733
(99 %)
6 diff
(99.2 %id)
BE742975 adenocarcinoma cell line, ovary .q 1 to 752 1 to 746   tiling clone,   746/986
(75 %)
22 diff
(97.8 %id)
CN481257 eye .q 305 to 911 1 to 606   tiling clone,   606/606
(100 %)
3 diff
(99.6 %id)
BE315469 adenocarcinoma cell line, ovary .r 1 to 589 1 to 589   tiling clone,   589/623
(94 %)
0 diff
(100 %id)
BE899233 adenocarcinoma cell line, ovary .r 2 to 683 1 to 696 W124C L129S Q130A A131S F133L ... tiling clone,   693/988
(70 %)
41 diff
(95.9 %id)
CN401882 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .r 631 to 1279 1 to 649   tiling clone,   649/649
(100 %)
0 diff
(100 %id)
BQ006483 Chondrosarcoma, Left Pelvis .r 1075 to 1803 745 to 19   tiling clone, AAA   727/727
(100 %)
6 diff
(99.2 %id)
BQ002114 Chondrosarcoma, Left Pelvis .r 1256 to 1803 566 to 19   AAA   548/548
(100 %)
2 diff
(99.7 %id)
AI922640 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .r 1365 to 1803 440 to 1       440/440
(100 %)
1 diff
(99.8 %id)
TI_154088800   .r 1371 to 1803 552 to 120   AAA   433/537
(80 %)
1 diff
(99.9 %id)
AI923384 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .r 1455 to 1803 368 to 20   AAA   349/349
(100 %)
3 diff
(99.2 %id)
BX334921.
matches multiple genes
Placenta Cot 25-normalized .s 1 to 1024 1 to 1011 S148V V149* tiling clone, This clone was ignored, also hits gene FDPSL5 1011/1101
(91 %)
14 diff
(98.8 %id)
BG742098 skin .t 1 to 943 1 to 938 exact tiling clone,   938/943
(99 %)
16 diff
(98.4 %id)
BG828803 muscle, rhabdomyosarcoma .u 1 to 746 1 to 744 N133K L134P L135P E136G A137S ... tiling clone,   744/744
(100 %)
7 diff
(99.1 %id)
BG105319 adrenal cortex carcinoma, cell line, adrenal gland .va 1 to 664 1 to 657 exact tiling clone,   657/928
(70 %)
9 diff
(99.1 %id)
AV688464 hepatocellular carcinoma .va 301 to 689 1 to 387   tiling clone,   387/390
(99 %)
4 diff
(99.0 %id)
AV686067 hepatocellular carcinoma .va 301 to 689 1 to 387   tiling clone,   387/390
(99 %)
4 diff
(99.0 %id)
BE940172 uterus_tumor .va 662 to 995 1 to 341   tiling clone,   341/343
(99 %)
14 diff
(96.0 %id)
CN346013 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vb 1 to 584 1 to 584 exact tiling clone,   584/584
(100 %)
0 diff
(100 %id)
TI_57238013   .vc 1 to 628 36 to 662 I13D L14S L15A L16F G17R ...     634/662
(95 %)
8 diff
(98.8 %id)
BI909460 leukocyte .vc 1 to 628 3 to 629 I13D L14S L15A L16F G17R ... tiling clone,   629/629
(100 %)
3 diff
(99.6 %id)
BF336847 colon .vc 624 to 1088 482 to 13   tiling clone,   470/482
(97 %)
8 diff
(98.4 %id)
DW424591 Liver .vc 667 to 938 17 to 288   tiling clone,   272/288
(94 %)
6 diff
(98.0 %id)
DB106884 thymus .vd 1 to 550 2 to 551   tiling clone, to resequence, capped   550/550
(100 %)
1 diff
(99.9 %id)
CN430107 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vd 19 to 775 1 to 757   tiling clone,   757/757
(100 %)
3 diff
(99.7 %id)
W42480 senescent fibroblast .vd 47 to 410 15 to 381       367/381
(96 %)
6 diff
(98.5 %id)
CV810524 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vd 60 to 751 1 to 692       692/692
(100 %)
0 diff
(100 %id)
DA633788 Kidney .vd 83 to 657 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DW454460 Liver .vd 157 to 322 16 to 181       166/181
(91 %)
6 diff
(96.7 %id)
DB343002 thymus .vd 1605 to 2195 592 to 1 S108X Y109L S110Q H111P I112H ... tiling clone, to resequence,   592/592
(100 %)
1 diff
(99.9 %id)
W42545 senescent fibroblast .vd 1782 to 2195 418 to 2   tiling clone,   417/418
(99 %)
4 diff
(99.1 %id)
DW410202 Liver .ve-u 1 to 318 17 to 335   tiling clone,   319/335
(95 %)
6 diff
(98.3 %id)
BQ776528 Pancreas, Purified pancreatic islet .ve-u 43 to 586 544 to 1   tiling clone,   544/544
(100 %)
0 diff
(100 %id)
BQ632213 Pancreas, Purified pancreatic islet .ve-u 78 to 587 510 to 1       510/510
(100 %)
7 diff
(98.7 %id)
BU950308 Pancreas, Purified pancreatic islet .ve-u 78 to 586 509 to 1       509/509
(100 %)
7 diff
(98.7 %id)
DW435994 Liver .ve-u 90 to 327 16 to 254       239/254
(94 %)
6 diff
(97.7 %id)
DW454302 Liver .ve-u 90 to 255 16 to 182       167/182
(91 %)
6 diff
(96.8 %id)
DW413004 Liver .ve-u 111 to 415 17 to 322       306/322
(95 %)
6 diff
(98.2 %id)
DW444023 Liver .ve-u 111 to 319 17 to 226       210/228
(92 %)
2 diff
(99.2 %id)
AA680339 lung .ve-u 124 to 588 465 to 1   tiling clone,   465/466
(99 %)
2 diff
(99.6 %id)
CA775382 Pancreas, Purified pancreatic islet .ve-u 127 to 550 458 to 35       424/458
(92 %)
0 diff
(100 %id)
AW338042 adenocarcinoma, Pancreas .ve-u 157 to 609 456 to 4   tiling clone,   453/456
(99 %)
0 diff
(100 %id)
AV760374 bone marrow .vf 1 to 698 1 to 687 E13G K14R Q15I D16S V18S ... tiling clone,   687/709
(96 %)
32 diff
(95.5 %id)
BF981679 duodenal adenocarcinoma, cell line, small intestine .vg 1 to 697 1 to 702 H129A V130M S131Y T132L A133P ... tiling clone,   702/974
(72 %)
24 diff
(97.6 %id)
DA689957   .vh 1 to 534 2 to 535 exact tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
AL533768 brain, fetal brain .vi-u 1 to 997 30 to 1013 S30X tiling clone, fully sequenced,   984/1013
(97 %)
8 diff
(99.3 %id)
AL565251 brain, fetal brain .vi-u 971 to 2003 1023 to 1   tiling clone, fully sequenced,   1023/1023
(100 %)
22 diff
(97.9 %id)
BF754587 colon .vi-u 1596 to 1769 12 to 184       173/193
(89 %)
4 diff
(98.0 %id)
DB219242 trachea .vj 1 to 547 2 to 549 N2T tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DA509361 brain .vk 1 to 579 2 to 583 L28P T29D E30L D31R E32M ... tiling clone, capped   582/582
(100 %)
3 diff
(99.5 %id)
BE182883 head_neck .vl-u 1 to 355 64 to 418   tiling clone,   355/418
(84 %)
6 diff
(98.6 %id)
BE182887 head_neck .vl-u 1 to 376 27 to 403 I41R tiling clone,   377/403
(93 %)
6 diff
(98.6 %id)
DA592932 lung .vm 1 to 523 2 to 524   tiling clone, capped   523/523
(100 %)
0 diff
(100 %id)
DA623560 Kidney .vm 9 to 543 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
DB104567 thymus .vm 15 to 568 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA030784   .vm 16 to 503 2 to 489   capped   488/488
(100 %)
1 diff
(99.8 %id)
DA951212 Spleen .vm 16 to 499 2 to 486   capped   485/485
(100 %)
1 diff
(99.8 %id)
DA987920 synovial membrane tissue from rheumatioidarthritis .vm 16 to 560 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA872809 Prostate .vm 24 to 598 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA542612   .vm 44 to 754 2 to 715   capped   714/715
(99 %)
10 diff
(98.7 %id)
DA936897 Spleen .vm 49 to 617 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
CN346012 embryonic stem cells, DMSO-treated H9 cellline .vm 65 to 226 1 to 162       162/162
(100 %)
1 diff
(99.4 %id)
AK021828 whole embryo, mainly head .vm 87 to 2105 1 to 2019 exact tiling clone, available from FLJ,   2019/2019
(100 %)
7 diff
(99.7 %id)
AU119407 whole embryo, mainly head .vm 88 to 901 2 to 817   capped   816/821
(99 %)
15 diff
(98.2 %id)
AK022841   .vm 112 to 2105 1 to 1994 exact tiling clone, available from FLJ,   1994/1994
(100 %)
2 diff
(99.9 %id)
AU127647   .vm 113 to 771 2 to 661   capped   660/660
(100 %)
4 diff
(99.4 %id)
DB111922 thymus .vm 113 to 694 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA582266 lung .vm 122 to 680 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA651807   .vm 123 to 657 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DA696597   .vm 128 to 687 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CN278758 embryonic stem cells, cell lines H1, H7, andH9 .vm 140 to 726 11 to 597       587/597
(98 %)
6 diff
(99.0 %id)
CF142257 CNCAP(3)T-225 cell line, Prostate .vm 147 to 453 1 to 307       307/307
(100 %)
21 diff
(93.2 %id)
DB109052 thymus .vm 199 to 765 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB136040 thymus .vm 320 to 867 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
CN278759 embryonic stem cells, cell lines H1, H7, andH9 .vm 345 to 865 1 to 520       520/520
(100 %)
3 diff
(99.5 %id)
EC539526 Prostate .vm 700 to 785 86 to 1       86/100
(86 %)
0 diff
(100 %id)
AU145757 whole embryo, mainly head .vm 1516 to 2105 585 to 1       585/589
(99 %)
18 diff
(97.0 %id)
AU150168   .vm 1649 to 2105 455 to 1       455/549
(82 %)
7 diff
(98.8 %id)
DW409837 Liver .vm 1667 to 1987 17 to 337       321/337
(95 %)
6 diff
(98.3 %id)
H57741 liver and spleen .vm 1668 to 2107 447 to 1     Submitted on the opposite strand 447/450
(99 %)
17 diff
(96.3 %id)
DA439689 tongue, tumor tissue .vm 1862 to 2407 2 to 548   tiling clone, capped   547/547
(100 %)
3 diff
(99.5 %id)
BF373890 stomach_normal .vm 2103 to 2444 370 to 31       340/370
(91 %)
0 diff
(100 %id)
BF373737 stomach_normal .vm 2108 to 2435 328 to 1   tiling clone,   328/335
(97 %)
2 diff
(99.5 %id)
BG015105 placenta_normal .vm 2143 to 2480 366 to 28       339/366
(92 %)
0 diff
(100 %id)
BF373887 stomach_normal .vm 2150 to 2444 297 to 3   tiling clone,   295/297
(99 %)
0 diff
(100 %id)
CN265527 embryonic stem cells, cell lines H1, H7, andH9 .vm 2298 to 2762 12 to 476   tiling clone,   465/476
(97 %)
6 diff
(98.8 %id)
H93403 liver and spleen .vm 2643 to 2959 1 to 321   tiling clone, fully sequenced,   321/321
(100 %)
8 diff
(97.6 %id)
H93404 liver and spleen .vm 2879 to 2975 99 to 1   tiling clone, fully sequenced,   99/99
(100 %)
0 diff
(100 %id)
AL534252 brain, fetal brain .vn 1 to 928 1 to 916 E30G D31G E32G E37R I38D ... tiling clone, fully sequenced,   916/916
(100 %)
60 diff
(93.5 %id)
BX422374 fetal liver, Liver .vn 56 to 878 1 to 821 A97L F98S F99S L100W V101W ... tiling clone,   821/821
(100 %)
7 diff
(99.2 %id)
DA056010 cerebellum .vn 136 to 710 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
AA359148 lung .vn 600 to 844 1 to 245       245/245
(100 %)
0 diff
(100 %id)
DW420445 Liver .vn 781 to 1067 14 to 300   tiling clone,   287/300
(95 %)
6 diff
(98.0 %id)
BI060645 uterus_tumor .vn 878 to 986 1 to 109       109/109
(100 %)
0 diff
(100 %id)
AL534251 brain, fetal brain .vn 898 to 1729 834 to 1   tiling clone, fully sequenced,   543/543
(100 %)
80 diff
(85.3 %id)
TI_57177695   .vo 1 to 811 33 to 850 exact tiling clone,   818/851
(96 %)
20 diff
(97.7 %id)
BI766386 pooled lung and spleen .vo 4 to 811 1 to 815 exact tiling clone,   815/816
(99 %)
15 diff
(98.2 %id)
AL568236 brain, fetal brain .vo 34 to 689 1 to 664 Q115T I116D C117L W118L Y119V ... tiling clone,   664/664
(100 %)
7 diff
(99.0 %id)
DA890614 rectum .vo 54 to 612 2 to 560   tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
AA452664   .vo 703 to 1267 1 to 566   tiling clone, fully sequenced,   566/566
(100 %)
11 diff
(98.1 %id)
BE775308 uterus .vo 819 to 1277 1 to 459   tiling clone,   459/459
(100 %)
9 diff
(98.1 %id)
TI_149284680   .vo 919 to 1691 850 to 82   tiling clone, AAA   769/1093
(70 %)
15 diff
(98.7 %id)
BX436162 fetal liver, Liver .vo 936 to 1690 756 to 1       756/940
(80 %)
30 diff
(96.9 %id)
BQ019845 Chondrosarcoma, Left Pubic Bone .vo 1012 to 1692 691 to 19   tiling clone, AAA   673/674
(99 %)
11 diff
(98.4 %id)
AL540108 brain, fetal brain .vo 1114 to 1628 519 to 1       519/662
(78 %)
14 diff
(97.9 %id)
AA527362 colon .vo 1115 to 1691 577 to 2       576/577
(99 %)
1 diff
(99.9 %id)
TI_149275304   .vo 1127 to 1691 645 to 81   AAA   565/566
(99 %)
8 diff
(98.6 %id)
AA450035   .vo 1265 to 1691 430 to 4   fully sequenced,   427/430
(99 %)
1 diff
(99.8 %id)
DA963498 stomach .vp-u 1 to 540 2 to 541   tiling clone, capped   540/540
(100 %)
1 diff
(99.9 %id)
DB342608.
matches multiple genes
thymus .vp-u 58 to 645 588 to 1     also hits gene sporawbu 588/588
(100 %)
0 diff
(100 %id)
AW009436 colon .vp-u 143 to 651 510 to 1       510/510
(100 %)
1 diff
(99.9 %id)
AW082130 pooled .vp-u 176 to 650 475 to 1       475/475
(100 %)
5 diff
(99.0 %id)
BF678282 Prostate .vp-u 181 to 657 1 to 475   AAA   475/475
(100 %)
13 diff
(97.3 %id)
AI022625 liver and spleen .vp-u 193 to 650 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
AI056800 liver and spleen .vp-u 193 to 650 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
AI362765 anaplastic oligodendroglioma, brain .vp-u 195 to 650 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
AI498920 anaplastic oligodendroglioma, brain .vp-u 207 to 650 442 to 1       442/465
(95 %)
9 diff
(98.1 %id)
EC574871 Prostate .vp-u 215 to 323 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
AI056529 liver and spleen .vp-u 218 to 650 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AA807442 germinal center B cell .vp-u 219 to 659 441 to 1       441/441
(100 %)
2 diff
(99.6 %id)
DW432666 Liver .vp-u 247 to 502 11 to 265       255/265
(96 %)
6 diff
(97.8 %id)
AI022307 liver and spleen .vp-u 268 to 650 383 to 1       383/383
(100 %)
0 diff
(100 %id)
ES316030 melanoma cell line .vp-u 277 to 730 38 to 493       456/493
(92 %)
6 diff
(98.8 %id)
AI762263 B-cell, chronic lymphotic leukemia .vp-u 303 to 794 490 to 1       490/490
(100 %)
5 diff
(99.0 %id)
CN430106 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vp-u 306 to 916 1 to 611   tiling clone,   611/611
(100 %)
3 diff
(99.6 %id)
AA766142 germinal center B cell .vp-u 319 to 805 497 to 11   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 487/487
(100 %)
2 diff
(99.6 %id)
AI873221 pooled .vp-u 380 to 650 271 to 1       271/271
(100 %)
2 diff
(99.3 %id)
DW413139 Liver .vp-u 405 to 712 15 to 321       307/321
(95 %)
6 diff
(98.2 %id)
AI926928 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .vp-u 449 to 805 356 to 1       356/356
(100 %)
2 diff
(99.5 %id)
CX873233 embryonic stem .vp-u 527 to 1237 1 to 711       711/711
(100 %)
1 diff
(99.9 %id)
AW752119 colon .vp-u 794 to 961 17 to 184       168/184
(91 %)
6 diff
(96.8 %id)
AW177536 colon .vp-u 802 to 961 1 to 160       160/160
(100 %)
1 diff
(99.4 %id)
AW178584 head_neck .vp-u 802 to 1344 1 to 543   tiling clone,   543/543
(100 %)
2 diff
(99.7 %id)
DB029806 testis .vp-u 810 to 1404 2 to 596   tiling clone, capped   595/595
(100 %)
1 diff
(99.9 %id)
AW366342 head_neck .vp-u 863 to 987 1 to 126       126/128
(98 %)
4 diff
(96.9 %id)
BF816537 colon_ins .vp-u 1135 to 1533 108 to 506 A43G L71S tiling clone,   501/506
(99 %)
10 diff
(98.1 %id)
DA999163 breast, tumor tissue .vq 1 to 550 2 to 552   tiling clone, capped   551/551
(100 %)
2 diff
(99.7 %id)
DB005479 breast, tumor tissue .vq 1 to 532 2 to 534   tiling clone, capped   533/533
(100 %)
2 diff
(99.7 %id)
CF597246 ovary .vq 8 to 697 1 to 699 G36R M50D P51A S52I M53N ... tiling clone,   699/807
(86 %)
23 diff
(97.2 %id)
378 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve-u, .vf, .vg, .vh, .vi-u, .vj, .vk, .vl-u, .vm, .vn, .vo, .vp-u, .vq Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI